Literature DB >> 26176495

Animal models of respiratory syncytial virus infection and disease.

Randy E Sacco1, Russell K Durbin2, Joan E Durbin3.   

Abstract

The study of human respiratory syncytial virus pathogenesis and immunity has been hampered by its exquisite host specificity, and the difficulties encountered in adapting this virus to a murine host. The reasons for this obstacle are not well understood, but appear to reflect, at least in part, the inability of the virus to block the interferon response in any but the human host. This review addresses some of the issues encountered in mouse models of respiratory syncytial virus infection, and describes the advantages and disadvantages of alternative model systems.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2015        PMID： 26176495      PMCID： PMC4699663          DOI： 10.1016/j.coviro.2015.06.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN： 1879-6257            Impact factor:   7.090


  51 in total

1.  The role of IFN in respiratory syncytial virus pathogenesis.

Authors:  Joan E Durbin; Teresa R Johnson; Russell K Durbin; Sara E Mertz; Rafaella A Morotti; R Stokes Peebles; Barney S Graham
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

2.  A respiratory syncytial virus of bovine origin.

Authors:  M F Paccaud; C Jacquier
Journal:  Arch Gesamte Virusforsch       Date:  1970

3.  Nomi virus, a virus isolated from an apparently new epizootic respiratory disease of cattle.

Authors:  Y Inaba; Y Tanaka; K Sato; H Ito; T Omori
Journal:  Jpn J Microbiol       Date:  1970-05

4.  Lymphocyte populations and adhesion molecule expression in bovine tonsils.

Authors:  M C Rebelatto; C Mead; H HogenEsch
Journal:  Vet Immunol Immunopathol       Date:  2000-01-31       Impact factor: 2.046

5.  Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells.

Authors:  Birgit Bossert; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Cytotoxic T lymphocyte activity and cytokine expression in calves vaccinated with formalin-inactivated bovine respiratory syncytial virus prior to challenge.

Authors:  Amelia R Woolums; Robert A Gunther; Kerrie McArthur-Vaughan; Mark L Anderson; Amanda Omlor; Gabrielle A Boyle; Kathy E Friebertshauser; Pat S McInturff; Laurel J Gershwin
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2004-01       Impact factor: 2.268

7.  Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on cytokine messenger RNA expression following viral challenge in calves.

Authors:  Congrong Miao; Amelia R Woolums; Dante S Zarlenga; Corrie C Brown; James C Brown; Shamita M Williams; Melissa A Scott
Journal:  Am J Vet Res       Date:  2004-06       Impact factor: 1.156

Review 8.  Immunology of viral respiratory tract infection in infancy.

Authors:  James E Crowe; John V Williams
Journal:  Paediatr Respir Rev       Date:  2003-06       Impact factor: 2.726

9.  Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes.

Authors:  Ruth M Gaddum; Roy S Cook; Julie M Furze; Shirley A Ellis; Geraldine Taylor
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

Review 10.  Measuring the lung function in the mouse: the challenge of size.

Authors:  Charles G Irvin; Jason H T Bates
Journal:  Respir Res       Date:  2003-05-15
View more
  14 in total

1.  A gammaherpesvirus licenses CD8 T cells to protect the host from pneumovirus-induced immunopathologies.

Authors:  Bénédicte Machiels; Laurent Gillet; Mickaël Dourcy; Céline Maquet; Lorène Dams; Gautier Gilliaux; Justine Javaux; Daniel Desmecht; Matthias Mack; Benjamin G Dewals
Journal:  Mucosal Immunol       Date:  2020-05-18       Impact factor: 7.313

Review 2.  Innate immune responses in the ageing lung.

Authors:  D M Boe; L A Boule; E J Kovacs
Journal:  Clin Exp Immunol       Date:  2016-11-02       Impact factor: 4.330

3.  Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses.

Authors:  Jillian N Whelan; Kim C Tran; Damian B van Rossum; Michael N Teng
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

4.  A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.

Authors:  Jessica L Grieves; Zhiwei Yin; Adolfo Garcia-Sastre; Ignacio Mena; Mark E Peeples; Heidi P Risman; Hannah Federman; Marvin J Sandoval; Russell K Durbin; Joan E Durbin
Journal:  Vaccine       Date:  2018-05-18       Impact factor: 3.641

5.  A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.

Authors:  Stacey Human; Anne L Hotard; Larry J Anderson; Tina V Hartert; Martin L Moore; Christina A Rostad; Sujin Lee; Louise McCormick; Emma K Larkin; Teresa C T Peret; Jaume Jorba; Joseph Lanzone; Tebeb Gebretsadik; John V Williams; Melissa Bloodworth; Matthew Stier; Kecia Carroll; R Stokes Peebles
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

6.  Respiratory Syncytial Virus Aggravates Renal Injury through Cytokines and Direct Renal Injury.

Authors:  Songhui Zhai; Lijuan Hu; Lin Zhong; Yannan Guo; Liqun Dong; Ruizhen Jia; Zheng Wang
Journal:  Front Cell Infect Microbiol       Date:  2016-09-30       Impact factor: 5.293

7.  Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.

Authors:  Jodi L McGill; Sean M Kelly; Pankaj Kumar; Savannah Speckhart; Shannon L Haughney; Jamie Henningson; Balaji Narasimhan; Randy E Sacco
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

8.  Prophylactic digoxin treatment reduces IL-17 production in vivo in the neonatal calf and moderates RSV-associated disease.

Authors:  Jodi L McGill; Mariana Guerra-Maupome; Sarah Schneider
Journal:  PLoS One       Date:  2019-03-25       Impact factor: 3.240

9.  Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts.

Authors:  Koert J Stittelaar; Leon de Waal; Geert van Amerongen; Edwin J B Veldhuis Kroeze; Pieter L A Fraaij; Carel A van Baalen; Jeroen J A van Kampen; Erhard van der Vries; Albert D M E Osterhaus; Rik L de Swart
Journal:  Viruses       Date:  2016-06-14       Impact factor: 5.048

10.  Bovine Gamma Delta T Cells Contribute to Exacerbated IL-17 Production in Response to Co-Infection with Bovine RSV and Mannheimia haemolytica.

Authors:  Jodi L McGill; Rachel A Rusk; Mariana Guerra-Maupome; Robert E Briggs; Randy E Sacco
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.